Piroxantrone is an anthracycline antineoplastic agent that functions as an antibiotic, exerting its cytotoxic effect by intercalating into DNA and inhibiting topoisomerase II to induce cell death in rapidly… Read more
Piroxantrone is an anthracycline antineoplastic agent that functions as an antibiotic, exerting its cytotoxic effect by intercalating into DNA and inhibiting topoisomerase II to induce cell death in rapidly dividing malignancy. Primarily indicated for treating advanced breast cancer and non-Hodgkin's lymphoma in patients who have failed prior chemotherapy regimens, this drug requires precise analytical oversight. The collection of Piroxantrone reference standards, including the hydrochloride form, associated metabolites like 10-hydroxy-piroxantrone, and stable isotope-labelled compounds, provides essential tools for pharmaceutical laboratories. Researchers use these high-quality materials for critical analytical testing, impurity profiling, and method validation to ensure consistent product safety and efficacy. These standards are indispensable for quantitative analysis and rigorous quality control during the development and manufacturing of therapeutic agents, ensuring that regulatory requirements for drug purity and stability are accurately met throughout the product lifecycle.